INSILICO (03696) saw its shares climb close to 4% during the morning session. At the time of writing, the stock was up 2.49%, trading at HKD 70.05, with a turnover of HKD 98.23 million. The positive movement follows an announcement from the company's official WeChat account on April 21. INSILICO will present four AI-driven preclinical research findings, including results for ISM6166, at the 2026 American Association for Cancer Research (AACR) Annual Meeting. Supported by generative artificial intelligence, this marks the fourth consecutive year the company has participated in AACR with research projects. All four of the selected preclinical studies, which focus on internally developed oncology pipelines, will be featured in the poster presentation session. Notably, two of the selected studies are innovative projects initiated by INSILICO's research and development center in the UAE.
Comments